Fulvestrant plus capivasertib for metastatic breast cancer. Ludmir EB, McCaw ZR, Kim DH, Tian L, et al. Lancet Oncol 2020;21:e233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ludmir EB, McCaw ZR, Kim DH, Tian L, et al. Fulvestrant plus capivasertib for metastatic breast cancer. Lancet Oncol 2020;21:e233.
PMID: 32359498